DrStore Healthcare Services India, a leading connected healthcare and medical device company, has joined forces with TatvaCare’s Health & Wellness app GoodFlip to expand access to Continuous Glucose Monitoring (CGM) technologies and strengthen India’s digital diabetes care infrastructure.
As metabolic diseases like diabetes, obesity, and cardiovascular disorders rise globally, the convergence of connected medical devices, biosensing innovation, and digital health platforms is expected to drive preventive, personalised, and continuous care. With CGM adoption accelerating in India, connected technologies are increasingly becoming central to chronic disease management.
The collaboration integrates DrStore’s TRACKY, India’s first Bluetooth-enabled CGM system, with TatvaCare’s GoodFlip platform, enabling real-time glucose monitoring and data-driven management of diabetes, chronic kidney disease, post-transplant metabolic care, and other metabolic conditions.
The partnership will deploy connected CGM solutions across digital care programs and specialised clinical pathways. By combining TRACKY’s biosensing technology with TatvaCare’s digital infrastructure, clinicians can monitor glucose trends remotely, supporting proactive, personalised care for high-risk patient groups nationwide.
Specialised care pathways will focus on patients with chronic kidney disease and those requiring post-transplant metabolic management—populations often facing significant glycaemic fluctuations due to immunosuppressive therapies, steroid use, and complex metabolic changes. Continuous glucose monitoring is expected to improve glycaemic control and clinical outcomes for these patients.
TRACKY, launched in 2025, marked a breakthrough in India’s CGM landscape, enabling seamless real-time glucose data transmission and integrating diabetes monitoring into a broader, data-driven metabolic health ecosystem.
“Continuous monitoring technologies are redefining how metabolic diseases are managed globally,” said Neeraj Katare, Founder of DrStore Healthcare Services India Private Limited.
“With TRACKY, our vision has been to build a connected biosensing platform that integrates advanced medical devices with digital health ecosystems. Launching India’s first Bluetooth-connected CGM was an important step in that journey. As adoption of continuous monitoring accelerates, we see tremendous potential in building an integrated metabolic monitoring ecosystem that enables clinicians and patients to move from episodic testing to real-time, data-driven care.”
“Digital health platforms are playing an increasingly critical role in enabling more personalised and continuous care pathways,” said Manoj Balaji, Chief Executive Officer at TatvaCare.
“By integrating TRACKY’s connected CGM technology within TatvaCare’s ecosystem, we aim to extend access to clinicians with deeper metabolic insights and enable patients to benefit from more proactive and technology-enabled disease management.”
The collaboration is part of TRACKY’s broader mission to build an integrated continuous metabolic monitoring platform extending beyond glucose to multiple metabolic and cardiovascular biomarkers. The company is also exploring digital health applications for metabolic therapy management, including emerging models around GLP-1-based weight-loss therapies.
